Volume 58, Issue 4, Pages (October 2000)

Slides:



Advertisements
Similar presentations
Volume 131, Issue 1, Pages (July 2006)
Advertisements

Volume 61, Issue 1, Pages (January 2002)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Htr-9 stimulates ICAM-1 gene expression in human ASM cells.
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta 
Volume 69, Issue 6, Pages (March 2006)
Volume 117, Issue 1, Pages (July 1999)
Volume 69, Issue 9, Pages (May 2006)
Volume 60, Issue 4, Pages (October 2001)
Volume 60, Issue 2, Pages (August 2001)
Boye L. Jensen, Bianca Mann, Ole Skøtt, Armin Kurtz 
Human mesangial cells express inducible macrophage scavenger receptor
Volume 65, Issue 2, Pages (February 2004)
Volume 60, Issue 5, Pages (November 2001)
Volume 62, Issue 4, Pages (October 2002)
Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes1  Joerg Plum, Mohammad.
Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts  Ghassan M Saed,
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 67, Issue 4, Pages (April 2005)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
Volume 64, Issue 5, Pages (November 2003)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 65, Issue 4, Pages (April 2004)
Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta 
Expression of inter-α-trypsin inhibitor and tumor necrosis factor-stimulated gene 6 in renal proximal tubular epithelial cells  Ulf Janssen, Gareth Thomas,
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
Volume 67, Issue 3, Pages (March 2005)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 59, Issue 4, Pages (April 2001)
Volume 54, Issue 2, Pages (August 1998)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 57, Issue 5, Pages (May 2000)
Volume 67, Issue 2, Pages (February 2005)
Volume 65, Issue 6, Pages (June 2004)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Volume 60, Issue 2, Pages (August 2001)
Noritaka Oyama, Keiji Iwatsuki, Yoshimi Homma, Fumio Kaneko 
Volume 55, Issue 6, Pages (June 1999)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 61, Issue 1, Pages S106-S109 (January 2002)
Volume 117, Issue 1, Pages (July 1999)
Volume 53, Issue 4, Pages (April 1998)
Volume 85, Issue 2, Pages (January 2014)
Hongli Lin, Xiangmei Chen, Jianzhong Wang, Zhiheng Yu 
RNA Polymerase II Activity of Type 3 Pol III Promoters
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Cloning of a novel gene in the human kidney homologous to rat munc13s: Its potential role in diabetic nephropathy  Yong Song, Menachem Ailenberg, Mel.
Eva Balint, Cory F. Marshall, Dr Stuart M. Sprague 
Volume 61, Issue 5, Pages (May 2002)
Volume 56, Pages S178-S181 (July 1999)
Tohru Umekawa, Nasser Chegini, Saeed R. Khan, Ph.D. 
Volume 57, Issue 2, Pages (October 2000)
Volume 56, Issue 5, Pages (November 1999)
Volume 55, Issue 3, Pages (March 1999)
Volume 64, Issue 6, Pages (December 2003)
Volume 70, Issue 5, Pages (September 2006)
Volume 67, Issue 6, Pages (June 2005)
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Volume 55, Issue 2, Pages (February 1999)
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Cultured human glomerular mesangial cells express the C5a receptor
Volume 56, Issue 5, Pages (November 1999)
Permeability Barrier Disruption Increases the Level of Serine Palmitoyltransferase in Human Epidermis  Francesca Alessandrini, Dr., Heidrun Behrendt 
Volume 58, Issue 6, Pages (December 2000)
Oxalate stimulates IL-6 production in HK-2 cells, a line of human renal proximal tubular epithelial cells  M.E.I. Y.I. Huang, Lakshmi S. Chaturvedi, Sweaty.
Volume 72, Issue 2, Pages (July 2007)
Volume 60, Issue 5, Pages (November 2001)
Presentation transcript:

Volume 58, Issue 4, Pages 1534-1545 (October 2000) Diabetes mellitus increases endothelin-1 gene transcription in rat kidney  Gaylene M. Hargrove, Josee Dufresne, Catharine Whiteside, Daniel A. Muruve, Norman C.W. Wong  Kidney International  Volume 58, Issue 4, Pages 1534-1545 (October 2000) DOI: 10.1046/j.1523-1755.2000.00315.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 DM increases urinary levels of ET-1. (A) The rise in blood glucose and urinary volumes in diabetic rats compared with controls over a time period of three months. Additionally, total body weight declined in the diabetic rats compared with controls. (B) The rise in total urinary protein and ET-1 peptide in the same animals. Each value reflects the mean ± SD. **P < 0.01, according to analysis of variance of data. Kidney International 2000 58, 1534-1545DOI: (10.1046/j.1523-1755.2000.00315.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 DM increases renal ET-1 mRNA. (A) An ethidium bromide stained gels of RT-PCR products that reflect ET-1 mRNA abundance in total kidney RNA from a diabetic (upper) and control (lower) rat. The intensity of the bands was plotted as a function of cycle number and shows a linear rise in the product between 26 and 32 cycles of PCR. (B) The relative abundance of ET-1 mRNA in total kidney RNA from controls (4) and diabetic (10) rats. Each value reflects the mean ± SD. Analysis of variance showed a significant difference between the diabetic and control rats with P < 0.05. Kidney International 2000 58, 1534-1545DOI: (10.1046/j.1523-1755.2000.00315.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Glucose increases ET-1 expression in primary cultured mesangial cells. (A) The increased ET-1 peptide, as detected by immunoflorescence, in primary cultured mesangial cells correlates with rising concentrations of glucose (5.6, 11.2, and 22.5mmol/L) in the media. (B) Ethidium bromide-stained agarose gels containing products of RT-PCR that reflect the abundance of ET-1 and β-actin mRNA in primary cultured mesangial cells exposed to 5.6, 11.2, and 22.5mmol/L glucose. (C) A graph showing the increase in ER-1 mRNA as a function of rising concentrations of glucose in the media. Each value reflects the mean ± SD. *P < 0.05; **P < 0.01, as determined by analysis of variance. Kidney International 2000 58, 1534-1545DOI: (10.1046/j.1523-1755.2000.00315.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Glucose increases ET-1 mRNA in mesangial cells. (A) RT-PCR products that reflect the levels of ET-1 mRNA from primary culture mesangial cells exposed to 5.6 or 22.5mmol/L D-/L-glucose at 0 time, lanes 1 through 3. Lanes 4 through 6 show changes in the level of ET-1 mRNA following 24 hours of exposure to varying concentrations and isoforms of glucose. The RT-PCR product of β-actin mRNA appears below the ET-1 photographs, and the concentration of glucose is noted at the bottom of each lane. (B) The relative levels of ET-1 mRNA in primary culture mesangial cells exposed to 5.6 or 22.5mmol/L D-/L-glucose for 24 hours. Each bar reflects the mean ± SD of at least three separate experiments. (C) An autoradiograph of results using RNase protection. Lane 1, probe alone; lanes 2 and 3, abundance of ET-1 cRNA protected in 10 μg of total mRNA from mesangial cells treated with 5.6mmol/L glucose for 24 hours; lanes 4 and 5, abundance of ET-1 cRNA protected in 10 μg of total mRNA from mesangial cells treated with 22.5mmol/L glucose for 24 hours. Kidney International 2000 58, 1534-1545DOI: (10.1046/j.1523-1755.2000.00315.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Activity of ET-1 promoter is enhanced by glucose. (A) A schematic map showing the site of several restriction enzymes in pET1.Luc, a plasmid that contains the rat ET-1 promoter fused to the reporter gene luciferase. (B) An ethidium bromide stained agarose gel of fragments arising from the digestion of the pET1.Luc with Kpn I and Xba I. (C) Autoradiographs (left) and a graph (right) of CAT-activity from three separate cotransfections of cells with pSV2-CAT and pET1.Luc for each group of treatment with 5.6 or 22.5mmol/L glucose. Each bar shows the mean ± SD of at least four separate experiments. (D) A graph showing increased relative ET-1 promoter activity (calculated as described in the Methods section) in primary cultured mesangial cells transfected with pET1.Luc followed by treatment with 5.6 or 22.5mmol/L D-glucose. Each bar shows the mean ± SD of at least four separate experiments. Kidney International 2000 58, 1534-1545DOI: (10.1046/j.1523-1755.2000.00315.x) Copyright © 2000 International Society of Nephrology Terms and Conditions